Cellular and molecular pathogenesis of cervical carcinoma;Papillomavirus ey cancer du col de l'uterus

Medecine/Sciences

Volumn 12, Issue 6-7, 1996, Pages 733-744

  Monsonego, Joseph ^a,b  

^a Institut A Fournier   (France)

^b INSTITUT ALFRED FOURNIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

ANEUPLOIDY; ARTICLE; CELL CYCLE; DNA INTEGRATION; FEMALE; HUMAN; NONHUMAN; PRECANCER; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0029898616     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/814     Document Type: Article

References (55)

1. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix : relative risk associations of 15 common anogenital types. Obstet Gynecol 1992 ; 79 : 328-37.
2. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res 1989 ; 489 : 4677-81.
3. Pirisi L, Yasumoto M, Feller J, Doniger J, DiPaolo JA. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987; 61 : 1061-6.
4. Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical cancer. J Virol 1989 ; 63 : 159-64.
5. Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989 ; 63 : 4417-21.
6. Pecoraro G, Lee M, Morgan D, De Fendi V. Evolution of in vitro transformation and tumorogenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells. Am J Pathol 1991 ; 138 : 1-8.
7. Davies R, Hicks R, Crook T, Morris J, Vousden K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 1993; 67: 2521-8.
8. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990 ; 63 : 1129-38.
9. Münger K, Werness BA, Dyson N, Harlow E. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989 ; 8 : 4099-105.
10. Wolowiec D, Ffrench M. Kinases dépendantes des cyclines: rôle biologique et implications dans la pathologie humaine, médecine/sciences 1996 ; 12 : 165-73.
11. Clavel Ch, Zerat L, Binninger I, Boutterin MC, Polette M, Monsonego J, Birembaut P. DNA content measurement and in situ hybridization in condylomatous cervical lesions. Diag Mol Pathol 1992; 1: 180-4.
12. Monsonego J, Zerat L, Clavel C, Birembaut P. ADN ploïdie des CIN : confrontations histo-virologiques et intérêts pratiques. Gynécologie 1992 ; 43 : 22-8.
13. von Knebel Doeberitz M, Rittmüller C, Aengeneyndt F, Jansen-Dürr P, Spitkovsky D. Reversible repression of Papillomavirus oncogene expression in cervical carcinoma cells : Consequences for the phenotype and E6-p53 and E7-pRb interactions. J Virol 1994 ; 68-5 : 2811-21.
14. Lane DP, Crawford VL. T antigene is bound to a host protein in SV40-transformed cells. Nature 1979 ; 278 : 261-3.
15. Donehower LA, Harvey M, Slagle BL et al Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992 ; 356 : 215-21.
16. Soussi T, p16, p21 (WAF1/CIP1), P27(Kip1) et p53: rivales ou compagnes? médecine/sciences 1994 ; 10 : 744-6.
17. Kern SE, Kinzler KW, Baker SJ et al. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 1991 ; 6 : 131-6.
18. Farmer G, Bargonetti J, Shu H et al. Wild-type p53 activates transcription in vitro. Nature 1992 ; 358 : 83-6.
19. Crook T, Tidy J, Vousden K Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and transactivation. Cell 1991 ; 67: 547-6.
20. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH Clonal p53 mutation in primary cervical cancer : association with human-papillomavirus-negative tumours. Lancet 1992 ; 339 : 1070-3.
21. Werness B, Levine AJ, Howley G. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990 ; 248 : 76-9.
22. Kaelbling M, Burck RD, Atkin NB, Klinger HP. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV negative cervical carcinomas, Lancet 1992 ; 340 : 140-2.
23. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990 ; 335 : 1171-4.
24. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992 ; 52 : 5323-8.
25. Monsonego J. HPV and cofactors in cervical carcinogenesis. In: Papillomaviruses in human pathology, New York: ed. Raven Press, 1990 : 31-48.
26. Rösl F, Dürst M, zur Hausen H. Selective suppression of human papillomavirus transcription in non-tumorigenic cells by 5-azacytidine. EMBO J 1988 ; 7 : 1321-7.
27. Rösl F, Achtastätter T, Bauknecht T, Futterman G, Hutter KJ, zur Hausen H. Extinction of the HPV 18 up-stream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J 1991 ; 10 : 1337-45.
28. Haskell KM, Vuocolo GA, Defoe-Jones D, Jones RE, Ivey-Hoyle M. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to retinoblastoma gene product. J Gen Virol 1993 ; 74 : 115-9.
29. Jewers RJ, Hildebrandt P, Ludlow JW, Kell B, McCance DJ. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J Virol 1992 ; 66 : 1329-35.
30. Zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: Zur Hausen H, ed. Human pathogenic papillomaviruses. Berlin: Springer-Verlag, 1994 : 131-56.
31. Bosch FX, Schwarz E, Boukamp P, Fusenig NE, Bartsch D, zur Hausen H Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in non-tumorigenic HeLa-fibroblast hybrid cells. J Virol 1990 ; 64 : 4743-54.
32. Chen TM, Pecoraro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res 1993 ; 53 : 1167-71.
33. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994 ; 343 : 955-7.
34. Cromme FV, Snijders PJF, van den Vrule AJC, Kenemans P, Meijer CJLM, Walboomers JMM. CMH class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. Oncogene 1993 ; 8 : 2969-75.
35. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNA's in intraepithelial and invasive cervical neoplasms. J Virol 1991 ; 65 : 606-12.
36. Romanczuk H, Thierry F, Howley G. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105. J Virol 1990 ; 64 : 2849-59.
37. Romanczuk H, Howley G. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci USA 1992 ; 89 : 3159-63.
38. Couturier J, Sastre-Gareau X, Schneider-Maunoury S, Labib A, Orth G. Integration of papillomavirus DNA near myc genes in genital carcinomas and consequence on protooncogene expression. J Virol 1990 ; 65 : 4534-8.
39. Saewha J, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into human genome correlates with a selective growth advantage of cells. J Virol 1995 ; 69-5 : 2989-97.
40. Monsonego J, Zerat L, Catalan F, Coscas Y. Genital human papillomavirus infections : correlation of cytological, colposcopic and histological features with viral types in women and their male partners. Int J STD AIDS 1993 ; 4 : 13-20.
41. Ferenczy A, Winkler B.: Cervical intraepithelial neoplasia and condyloma In Kurman RK, ed. Blanstein Pathology of the female genital tract. New York: Springler Verlag, 1987 : 177-217.
42. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO'D. Episomal and integrated HPV in cervical neoplasia demonstrated by non isotopic in situ hybridisation. J Clin Pathol 1991 ; 44 : 990-6.
43. Jenson AB, Lancaster WD. Association of human papillomavirus with benign, premalignant and malignant anogenital lesions. In : Pfister H ed. Papillomaviruses and human cancer. Boca Raton, Florida: CRC Press Inc, 1990 : 12-21.
44. Graham AK, Herrington CS, McGee JO'D. Sensitivity and specificity of monoclonal antibodies to human papillomavirus type 16 capsid protein : comparison with simultaneous viral detection by non isotopic in situ hybridisation. J Clin Pathal 1992 ; 44 : 96-101.
45. Wada Y, Fujinaga K. The physical state of human papillomavirus 16 DNA in cervical carcinoma and cervical intra-epithelial neoplasia. Cancer 1990 ; 66 : 2155-61.
46. Dagmar Dürst G, Schneider A, Zur Hausen H. Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992 ; 189 : 132-40.
47. Crum C, Symbula M, Ward B. Topography of early HPV16 transcription in highgrade genital precancers. Am J Pathol 1989 ; 134 : 1183-8.
48. Iftner T, Oft M, Böhm S, Wolczynski SP, Pfister H. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J Virol 1992 ; 66 : 4639-46.
49. Holm R, Skomedan H, Äslaug H, Kristensen G, Børresen AL, Nesland J. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol 1993 ; 169 : 21-6.
50. Kainz C, Kohlberger P, Gitsch G, Sliutz G, Brettenecker G, Reinthaller A. Mutant p53 in patients with invasive cervical cancer stages 1B to 2B. Gynecol Oncol 1995 ; 57 : 212-4.
51. Ter Harmsel B, van Belkum A, Quint W, Pronk A, Kuijpers J, Ramaekers F, Tandon A, Smedts F. p53 and human papilloma virus type 16 in cervical intraepithelial neoplasia and carcinoma. Int J Gynecol Pathol 1995 ; 14 : 125-33.
52. Pilotti S, et al. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diag Mol Pathol 1993 ; 2 : 248-56.
53. Vecchione A, Cermele Ch, Giovagnoli MR, Valli C, Alimandi M, Carico E, Esposito DI, Mariani-Constantini R, French D. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 1994 ; 55 : 343-8.
54. Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF, Chang EH. The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. Carcinogenesis 1992 ; 13 : 1273-5.
55. Bennett WP, Colby TV, Travis WD, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993 ; 53 : 4817-22.